Medhane Nilufar DPM entered the industry of Podiatrists in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6213910, which describes it as a Podiatrists. For further clarification, the SIC classifies this business under the code 8043 and described it as a Podiatrists. The business provides service to the B2C market.
To acquire more information, please contact Nilufar Medhane by calling (202) 741-3333 during business hours. You can also write to the business’ Single Location at 2150 Pennsylvania Avenue Nw, Washington, District of Columbia DC 20037. You can also visit the company’s website at katzencancer.org. View this business’ social media profiles on Twitter or on Facebbok .
Company: | Medhane Nilufar DPM |
Representative: | Nilufar Medhane |
Place of Business: | 2150 Pennsylvania Avenue Nw, Washington, DC 20037 |
Contact Number: | (202) 741-3333 |
Website: | katzencancer.org |
Type of Service: | Podiatrists |
SIC Number: | 8043 |
NAICS Number: | 6213910 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2010 |
Income/Year: | $500.000 to $999.999 |
Laborers: | 1 to 4 |
Share This Company: |
Medhane Nilufar DPM is a company operating from District of Columbia, District of Columbia providing professional Podiatrists and relevant B2C variables. It was founded in 2010 and registered with the SIC code 8043 as Podiatrists, and with the NAICS code 6213910 as Podiatrists.
With a current employee count of 1 to 4, Medhane Nilufar DPM has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Nilufar Medhane at (202) 741-3333 for related queries, or to locate its Single Location using the coordinates 38.901643,-77.04775.
The Single Location can also be found at the street address 2150 Pennsylvania Avenue Nw in Washington, District of Columbia 20037 and can be engaged online through the company website at katzencancer.org, the company Twitter , and Facebook page .